However, the high expression of E-cad in the primary compared to the metastatic tumours contradicts other previous studies, which reported significantly increased E-cad expression in metastatic breast cancer in the bone compared to primary tumours [54], and an increased expression of E-cad in metastatic lung nodules compared to primaries [55]. Here, CDH1 is linked to neoplasm.